NCT00659685View on ClinicalTrials.gov

Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

Ondansetron

ODT, single-dose, fasting

DRUG

Zofran ODT

Trial Locations (1)

H4N 2Y8

Algorithme Pharma, Laval

Sponsors

Collaborators (1)

Algorithme Pharma Inc
All Listed Sponsors
collaborator

Algorithme Pharma Inc

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00659685 - Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter